• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于乳腺癌的缺氧相关预后标志物的开发与验证

Development and validation of a hypoxia-related prognostic signature for breast cancer.

作者信息

Wang Jianxin, Wang Yuquan, Xing Ping, Liu Qianqi, Zhang Cong, Sui Yang, Wu Changjun

机构信息

Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

College of Bioinformatics, Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.

出版信息

Oncol Lett. 2020 Aug;20(2):1906-1914. doi: 10.3892/ol.2020.11733. Epub 2020 Jun 16.

DOI:10.3892/ol.2020.11733
PMID:32724434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7377061/
Abstract

Hypoxia, an important component of the tumor microenvironment, plays a crucial role in the occurrence and progression of cancer. However, to the best of our knowledge, a systematic analysis of a hypoxia-related prognostic signature for breast cancer is lacking and is urgently required. Therefore, in the present study, RNA-seq data and clinical information were downloaded from The Cancer Genome Atlas (TCGA) and served as a discovery cohort. Cox proportional hazards regression analysis was performed to construct a 14-gene prognostic signature (PFKL, P4HA2, GRHPR, SDC3, PPP1R15A, SIAH2, NDRG1, BTG1, TPD52, MAFF, ISG20, LALBA, ERRFI1 and VHL). The hypoxia-related signature successfully predicted survival outcomes of the discovery cohort (P<0.001 for the TCGA dataset). Three independent Gene Expression Omnibus databases (GSE10886, GSE20685 and GSE96058) were used as validation cohorts to verify the value of the predictive signature (P=0.007 for GSE10886, P=0.021 for GSE20685, P<0.001 for GSE96058). In the present study, a robust predictive signature was developed for patients with breast cancer, and the findings revealed that the 14-gene hypoxia-related signature could serve as a potential prognostic biomarker for breast cancer.

摘要

缺氧是肿瘤微环境的一个重要组成部分,在癌症的发生和发展中起着关键作用。然而,据我们所知,目前缺乏对乳腺癌缺氧相关预后特征的系统分析,这一分析亟待开展。因此,在本研究中,从癌症基因组图谱(TCGA)下载了RNA测序数据和临床信息,并将其作为发现队列。进行Cox比例风险回归分析以构建一个由14个基因组成的预后特征(PFKL、P4HA2、GRHPR、SDC3、PPP1R15A、SIAH2、NDRG1、BTG1、TPD52、MAFF、ISG20、LALBA、ERRFI1和VHL)。缺氧相关特征成功预测了发现队列的生存结果(TCGA数据集的P<0.001)。使用三个独立的基因表达综合数据库(GSE10886、GSE20685和GSE96058)作为验证队列,以验证预测特征的价值(GSE10886的P=0.007,GSE20685的P=0.021,GSE缉058的P<0.001)。在本研究中,为乳腺癌患者开发了一种强大的预测特征,研究结果表明,这一由14个基因组成的缺氧相关特征可作为乳腺癌潜在的预后生物标志物。

相似文献

1
Development and validation of a hypoxia-related prognostic signature for breast cancer.一种用于乳腺癌的缺氧相关预后标志物的开发与验证
Oncol Lett. 2020 Aug;20(2):1906-1914. doi: 10.3892/ol.2020.11733. Epub 2020 Jun 16.
2
Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.建立和验证一个用于乳腺癌患者的新型自噬相关基因特征。
Gene. 2020 Dec 15;762:144974. doi: 10.1016/j.gene.2020.144974. Epub 2020 Jul 22.
3
Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.缺氧和 m6A/m5C/m1A 调控基因特征的联合探索和验证用于肝癌预后预测。
BMC Genomics. 2023 Dec 14;24(1):776. doi: 10.1186/s12864-023-09876-3.
4
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.一个联合缺氧和免疫基因特征,用于预测三阴性乳腺癌的生存和风险分层。
Aging (Albany NY). 2021 Aug 2;13(15):19486-19509. doi: 10.18632/aging.203360.
5
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.乳腺癌患者自噬相关长链非编码RNA特征的鉴定与验证
Front Oncol. 2021 Feb 5;10:597569. doi: 10.3389/fonc.2020.597569. eCollection 2020.
6
Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.一种用于头颈部鳞状细胞癌预后和免疫原性评估的新型缺氧相关特征的开发与验证
Front Oncol. 2022 Nov 14;12:943945. doi: 10.3389/fonc.2022.943945. eCollection 2022.
7
Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.基于批量和单细胞RNA测序的多形性胶质母细胞瘤缺氧预后特征的鉴定
Cancers (Basel). 2024 Feb 1;16(3):633. doi: 10.3390/cancers16030633.
8
Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.乳腺癌联合缺氧和铁死亡预后特征的开发与验证
Front Oncol. 2023 Mar 14;13:1077342. doi: 10.3389/fonc.2023.1077342. eCollection 2023.
9
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.早期肺腺癌中一种稳健的免疫相关预后标志物的开发与验证
J Transl Med. 2020 Oct 7;18(1):380. doi: 10.1186/s12967-020-02545-z.
10
A systematic analysis of a potential metabolism-related prognostic signature for breast cancer patients.对乳腺癌患者潜在的代谢相关预后特征的系统分析。
Ann Transl Med. 2021 Feb;9(4):330. doi: 10.21037/atm-20-7600.

引用本文的文献

1
Phosphofructokinase-1 redefined: a metabolic hub orchestrating cancer hallmarks through multi-dimensional control networks.磷酸果糖激酶-1的重新定义:一个通过多维控制网络协调癌症特征的代谢枢纽。
J Transl Med. 2025 Aug 6;23(1):873. doi: 10.1186/s12967-025-06897-2.
2
SDC1 is a critical transmembrane proteoglycan in breast cancer.SDC1是乳腺癌中一种关键的跨膜蛋白聚糖。
World J Surg Oncol. 2025 May 16;23(1):193. doi: 10.1186/s12957-025-03840-z.
3
Telomere Maintenance-Related Genes are Essential for Prognosis in Breast Cancer.端粒维持相关基因对乳腺癌预后至关重要。

本文引用的文献

1
Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative.基于RNA测序的分类器对五种传统乳腺癌生物标志物预测的临床价值:来自基于人群的多中心瑞典癌症基因组分析网络-乳腺癌倡议的报告
JCO Precis Oncol. 2018 Mar 9;2. doi: 10.1200/PO.17.00135. eCollection 2018.
2
miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.miR-103a-3p 通过靶向肿瘤蛋白 D52 抑制前列腺癌细胞增殖和侵袭。
J Invest Surg. 2021 Sep;34(9):984-992. doi: 10.1080/08941939.2020.1738602. Epub 2020 Mar 13.
3
Breast Cancer (Dove Med Press). 2025 Feb 24;17:225-239. doi: 10.2147/BCTT.S506783. eCollection 2025.
4
Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures.定义癌症中的缺氧:缺氧基因表达特征的里程碑式评估。
Cell Genom. 2025 Feb 12;5(2):100764. doi: 10.1016/j.xgen.2025.100764. Epub 2025 Jan 31.
5
Computational Pathology Detection of Hypoxia-Induced Morphologic Changes in Breast Cancer.乳腺癌中缺氧诱导形态学变化的计算病理学检测
Am J Pathol. 2025 Apr;195(4):663-670. doi: 10.1016/j.ajpath.2024.10.023. Epub 2024 Dec 26.
6
Evaluating the prognostic potential of telomerase signature in breast cancer through advanced machine learning model.通过先进的机器学习模型评估端粒酶特征在乳腺癌中的预后潜力。
Front Immunol. 2024 Nov 28;15:1462953. doi: 10.3389/fimmu.2024.1462953. eCollection 2024.
7
A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy.一种新型的谱系追踪工具显示,缺氧肿瘤细胞会导致放疗后肿瘤复发。
Radiother Oncol. 2025 Jan;202:110592. doi: 10.1016/j.radonc.2024.110592. Epub 2024 Oct 18.
8
Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.构建并验证一个与缺氧相关的基因特征,以预测乳腺癌的预后。
BMC Cancer. 2024 Apr 1;24(1):402. doi: 10.1186/s12885-024-12182-0.
9
ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway.ZC3H12A 通过抑制 IL-17 信号通路抑制低氧条件下乳腺癌的生长和转移。
Cell Cycle. 2024 Jan;23(2):188-204. doi: 10.1080/15384101.2024.2314441. Epub 2024 Feb 15.
10
Identifying key genes related to the peritubular capillary rarefaction in renal interstitial fibrosis by bioinformatics.通过生物信息学方法鉴定与肾间质纤维化小管周毛细血管稀疏相关的关键基因。
Sci Rep. 2023 Nov 10;13(1):19611. doi: 10.1038/s41598-023-46934-y.
Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis.
长链非编码RNA HULC通过miR-218/TPD52轴促进宫颈癌细胞的增殖、迁移和侵袭。
Onco Targets Ther. 2020 Feb 5;13:1109-1118. doi: 10.2147/OTT.S232914. eCollection 2020.
4
ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.ISG20 可作为一种潜在的生物标志物,并驱动肾透明细胞癌的肿瘤进展。
Aging (Albany NY). 2020 Jan 30;12(2):1808-1827. doi: 10.18632/aging.102714.
5
Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway.沉默 TPD52 通过抑制 Akt 通路抑制胰腺癌细胞的增殖、迁移和侵袭,但诱导其凋亡。
Neoplasma. 2020 Mar;67(2):277-285. doi: 10.4149/neo_2019_190404N295. Epub 2019 Dec 17.
6
Breast cancer.乳腺癌。
Nat Rev Dis Primers. 2019 Sep 23;5(1):66. doi: 10.1038/s41572-019-0111-2.
7
Panoptic View of Prognostic Models for Personalized Breast Cancer Management.个性化乳腺癌管理预后模型全景视图
Cancers (Basel). 2019 Sep 7;11(9):1325. doi: 10.3390/cancers11091325.
8
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer.开发和验证用于头颈部癌症的缺氧和免疫预后综合分类器。
Clin Cancer Res. 2019 Sep 1;25(17):5315-5328. doi: 10.1158/1078-0432.CCR-18-3314. Epub 2019 Jun 10.
9
The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression.SIAH2-NRF1 轴空间调节肿瘤微环境重塑以促进肿瘤进展。
Nat Commun. 2019 Mar 4;10(1):1034. doi: 10.1038/s41467-019-08618-y.
10
Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype.有氧糖酵解在癌症中的分子复杂性:对经典代谢表型的最新认识。
Crit Rev Biochem Mol Biol. 2018 Dec;53(6):667-682. doi: 10.1080/10409238.2018.1556578. Epub 2019 Jan 22.